Home Drugs SGLT2 inhibitors (drug class)
Registry trials: SGLT2 inhibitors (drug class) 14 registry trials linked to SGLT2 inhibitors (drug class) with start year 2022, of 94, newest start first. Assembled by a program from ClinicalTrials.gov. No person wrote or checked these pages, and they are counted apart from the pages that people wrote. Lists of trials come from the registry's own coding and may miss trials.
Each filter is a page of its own, so they work one at a time. Choose Whole list to start again.
Phase 4 Unknown status Planned start 2022-12-15 100 planned NCT05584319
Phase 4 Unknown status Planned start 2022-11-15 120 planned NCT05550441
Phase 4 Completed Started 2022-11-11 178 enrolled NCT05621551
Phase 3 Active, not recruiting Started 2022-11-08 1,750 planned NCT05374291
Phase 4 Unknown status Started 2022-11-05 100 planned NCT05600387
Phase 2 Completed Started 2022-10-01 220 enrolled NCT05179668
Phase 3 Unknown status Started 2022-09-16 100 planned NCT05020704
Phase 4 Completed Started 2022-09-01 100 enrolled NCT05735197
Phase 2 Recruiting Started 2022-06-08 222 planned NCT05359263
Phase 3 Active, not recruiting Started 2022-06-01 250 planned NCT05182658
Phase 3 Completed Started 2022-05-27 180 enrolled NCT05196347
Phase 3 Unknown status Started 2022-04-15 120 planned NCT05957887
Phase 2/3 Unknown status Started 2022-02-12 106 planned NCT05241431
Phase 4 Unknown status Started 2022-01-01 600 planned NCT05225077